Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Newborn Screening for Cystic Fibrosis in California.

Pediatrics - 1 Dec 2015

Kharrazi Martin, Yang Juan, Bishop Tracey, Lessing Shellye, Young Suzanne, Graham Steven, Pearl Michelle, Chow Helen, Ho Thomson, Currier Robert, Gaffney Leslie, Feuchtbaum Lisa

Abstract excerpt

OBJECTIVES: This article describes the methods used and the program performance results for the first 5 years of newborn screening for cystic fibrosis (CF) in California. METHODS: From July 16, 2007, to June 30, 2012, a total of 2,573,293 newborns were screened for CF by using a 3-step model: (1) measuring immunoreactive trypsinogen in all dried blood spot specimens; (2) testing 28 to 40 selected cystic fibrosis...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Algorithms
Share to California

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cystic Fibrosis

Share to Cystic Fibrosis Transmembrane Conductance Regulator

Share to Neonatal Screening

Share to Predictive Value of Tests

Share to Sensitivity and Specificity

Share to Trypsinogen

Source

Identifiers

PMID: 26574590
DOI: 10.1542/peds.2015-0811

Genes

CFTR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Newborn Screening for Cystic Fibrosis in California.PMID 26574590Read ↗

Screening for cystic fibrosis in New York State: considerations for algorithm improvements.Semantic proximity Read ↗

Novel CFTR variants identified during the first 3 years of cystic fibrosis newborn screening in California.Semantic proximity Read ↗

Genomic sequencing in cystic fibrosis newborn screening: what works best, two-tier predefined CFTR mutation panels or second-tier CFTR panel followed by third-tier sequencing?Semantic proximity Read ↗

Improving the Sensitivity and Positive Predictive Value in a Cystic Fibrosis Newborn Screening Program Using a Repeat Immunoreactive Trypsinogen and Genetic Analysis.Semantic proximity Read ↗

Cystic fibrosis newborn screening in Denmark: Experience from the first 2 years.Semantic proximity Read ↗

Four-year evaluation of neonatal cystic fibrosis screening in Southern Belgium.Semantic proximity Read ↗

Refinement of newborn screening for cystic fibrosis with next generation sequencing.Semantic proximity Read ↗

Utility of a very high IRT/No mutation referral category in cystic fibrosis newborn screening.Semantic proximity Read ↗

Detection of disease-causing CFTR variants in state newborn screening programs.Semantic proximity Read ↗

Newborn screening for CF in France: An exemplary national experience.Semantic proximity Read ↗

Newborn cystic fibrosis screening in southeastern Mexico: Birth prevalence and novel CFTR gene variants.Semantic proximity Read ↗

New York Cystic Fibrosis Newborn Screening Consortium Quality Improvement: Focus on Parent and Pediatrician Education and Develop a Statewide Standard of Care for CF-Related Metabolic Syndrome infants.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.